Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists

This publication has 23 references indexed in Scilit:

• The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
• Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
  Biological Psychiatry, 2011
• mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
  Science, 2010
• On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
  Psychopharmacology, 2010
• Elevated level of metabotropic glutamate receptor 2/3 in the prefrontal cortex in major depression
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010
• From synapse to nucleus: Novel targets for treating depression
  Neuropharmacology, 2010
• mGluR-Dependent Long-Term Depression Is Associated with Increased Phosphorylation of S6 and Synthesis of Elongation Factor 1A but Remains Expressed in S6K-Deficient Mice
  Molecular and Cellular Biology, 2008
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
  Nature Reviews Drug Discovery, 2008
• The selectivity of protein kinase inhibitors: a further update
  Biochemical Journal, 2007
• 2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability
  Journal of Medicinal Chemistry, 1998